CURRENT ALLERGY & CLINICAL IMMUNOLOGY JOURNAL OF THE ALLERGY SOCIETY OF SOUTH AFRICA
Vol 39, No 4 December 2026
- First do no harm (non-maleficence) in allergy practice
- Presenting allergy to the general population
- The burden of allergic disease in deprived populations
- Understanding and measuring patient experience of allergic and immune disorders
- Core outcome sets in allergic diseases
- Merging the arts, philosophy and history
- Occupational asthma in a mushroom farm worker
- Pruritic dermatoses in pregnancy
- A rare presentation of a drug-induced eczematous eruption
Please note this content is only available for Registered Healthcare Professionals Members.
Should you wish to access this content, please REGISTER or LOGIN on the platform.
GUEST EDITORIAL
Author: John O Warner
Abstract: As I reflected on my career in academic medicine, I discovered kindred thoughts expressed by Isaac Casaubon (1559–1614). He was a French Huguenot and a classical scholar who spent his later years in England and was buried in Westminster Abbey. He wrote: In research the horizon recedes as we advance and is no nearer at sixty than it was at twenty. As the power of endurance weakens with age, the urgency of the pursuit grows more intense … And research is always incomplete. As I move, hopefully very slowly, towards Shakespeare’s 7th stage of man (sans teeth, sans eyes …), I become ever more desperate to see my research endeavours having an impact.
Ethics article
FIRST DO NO HARM (NON-MALEFICENCE) IN ALLERGY PRACTICE
Author: Fezaan Desai
Background: The principle of primum non nocere, or ‘first, do no harm’, remains a foundational tenet of medical ethics. However, its application within allergy and immunology (A&I) presents complex considerations, particularly where diagnostic and therapeutic interventions carry inherent risks. Despite advances in the field, the intersection of bioethics and A&I remains under-explored.
Discussion: This article examines the principle of non-maleficence in allergy research, diagnostic skin testing and the use of biological agents. In research, the ethical justification of clinical trials requires careful consideration of participant selection, vulnerability, informed consent, and the proportionality of anticipated risks and benefits. In skin testing, potential harms include systemic allergic reactions, anaphylaxis and the consequences of false-positive results, highlighting the importance of clinically indicated investigations and appropriate risk mitigation. Similarly, biological agents offer substantial therapeutic benefits but introduce concerns regarding adverse effects, uncertain long-term efficacy, financial burden and equitable access to treatment. These considerations are particularly pertinent within South Africa, where socio-economic disparities and resource constraints may exacerbate individual and population-level harms.
Conclusion: Non-maleficence requires more than the avoidance of immediate physical injury; it necessitates the prevention of avoidable harm through evidence-based practice, appropriate patient selection and proportionate risk assessment. Ultimately, ethical A&I practice requires balancing clinical advancement against the obligation to minimise harm while recognising the broader implications of the allocation of healthcare resources.
Keywords: non-maleficence, allergy and immunology, intradermal skin testing, biological agents, research ethics
Opinion
PRESENTING ALLERGY TO THE GENERAL POPULATION: MAKING A COMPLEX SPECIALTY UNDERSTANDABLE
Authors: Jason Thoresen, Di Hawarden
Abstract: Although allergy is familiar to the public, it is often poorly understood. It may be associated with a blocked nose, an itchy rash, food reactions or a life-threatening emergency. So the question inevitably arises: ‘How can we explain a specialty that crosses so many organ systems without making every symptom sound allergic?’ This opinion piece proposes a practical approach: help people to recognise possible allergic patterns, to understand when a reaction is dangerous and to know what to do next. The clinical history remains central and testing should support rather than replace it. In South Africa, these messages need to reach beyond specialist consulting rooms into households, community pharmacies, primary healthcare and schools, together with guidance on when to seek further assessment.
Keywords: allergy, health literacy, anaphylaxis, public education, South Africa, sensitisation
Review article
THE BURDEN OF ALLERGIC DISEASE IN DEPRIVED POPULATIONS: INSIGHTS FROM SOUTH AFRICA IN A GLOBAL CONTEXT
Author: Christina J Jones
Abstract: South Africa offers a striking natural example of how social and environmental context shapes allergic disease. Prevalence has historically been low in rural communities but rises steeply with urbanisation and rises further still when urban migration leads into informal, poorly resourced settlements rather than into stable, well-resourced urban environments. This article draws on South Africa’s own epidemiological evidence (including large urban-rural cohort studies, migration research and studies from informal settlements), alongside international evidence, largely from the USA, UK and Australia, demonstrating that allergic disease similarly places a disproportionate burden on socioeconomically deprived and ethnic minority communities in high-income countries. Read together, these findings suggest that the drivers of allergic disease prevalence are not necessarily the same as the drivers of allergic disease burden. Urbanisation and environmental transition appear to increase the risk of developing allergic disease, whereas poverty, chronic psychosocial stress and barriers to healthcare more consistently compromise disease control, morbidity and clinical outcomes once disease is established. Addressing these inequalities requires coordinated, culturally and contextually appropriate interventions across policy, healthcare systems, clinical practice and communities. South Africa’s distinctive epidemiological gradient and growing research base position it well to lead future research and service innovation in this field.
Keywords: allergic disease, socioeconomic deprivation, health inequality, informal settlements, South Africa
Review article
UNDERSTANDING AND MEASURING PATIENT EXPERIENCE OF ALLERGIC AND IMMUNE DISORDERS TO IMPROVE CARE: AN OVERVIEW OF THE CONTEXT, APPROACHES AND GUIDANCE FOR A SOUTH AFRICAN SETTING
Authors: Amy Tallett, Alan J Poots, Caroline Killpack
Abstract: Patient experience is increasingly being recognised as a core component of care quality, together with clinical effectiveness and patient safety. For individuals with allergic and immune disorders, care pathways are often complex, involving long-term management, multiple care settings and substantial patient and caregiver involvement. Understanding patients’ experiences of care is therefore critical to achieving optimal outcomes. A range of approaches can be used to capture patient experience, including qualitative methods and patient-experience surveys, sometimes referred to as patient-reported experience measures (PREMs). Patient experience surveys offer a systematic and scalable means of understanding the performance of a healthcare system, service or provider, identifying priorities for improvement and monitoring change over time. However, it is essential that they are developed to measure what matters most to patients and to provide actionable insights for the improvement of the quality of their experience. We outline robust approaches to designing, testing and improving questionnaires, and share learnings from our paediatric allergy patient-experience survey development. We conclude by highlighting the need for context-specific patient surveys in South Africa to support meaningful and person-centred care.
Keywords: patient experience, patient satisfaction, quality of healthcare, allergy, immunology, person-centred care, healthcare surveys
Review article
CORE OUTCOME SETS IN ALLERGIC DISEASES
Authors: Anastasiia Demidova, Anastasiia Kiseleva, Daniel Munblit
Abstract: Allergy trials may measure different outcomes, or the same outcome in different ways, and may miss what matters most to patients, rendering studies difficult to compare. A core outcome set is the agreed minimum set of outcomes to measure and report in all studies of a defined condition and setting; a core outcome measurement set specifies how to measure them. In this narrative review we explain how these sets are developed and appraised, summarise selected initiatives and consider their use in South African research and clinical audits. Examples from asthma, atopic eczema, immunoglobulin E-mediated food allergy, eosinophilic oesophagitis and hereditary angioedema show why physiological measures, symptoms and patients’ experience need to be assessed together. Recommendations for allergic rhinoconjunctivitis and urticaria illustrate the harmonisation outside formal core outcome sets. However, agreeing on what to measure does not guarantee valid instruments, justify a composite score or ensure uptake. Good implementation requires transparent set selection, meaningful patient involvement, suitable language and age versions, feasible data collection and complete reporting. Core outcome sets can render research more useful when used within their scope and backed by measurement evidence. South African participation in their development, validation and implementation can help make them applicable across local care settings.
Keywords: core outcome sets, allergy, clinical immunology, patient-reported outcomes, outcome measurement
Review article
MERGING THE ARTS, PHILOSOPHY AND HISTORY INTO A HOLISTIC PARSIMONIOUS APPROACH TO CLINICAL ALLERGY
Author: John O Warner
Introduction: As I read historical documents describing allergic disorders and their management, I am struck by the insightful statement by Sir Patrick Cullen to Sir Colenso Ridgeon in Act 1 of The Doctor’s Dilemma by George Bernard Shaw: Don’t misunderstand me, my boy. I’m not belittling your discovery. Most discoveries are made regularly every fifteen years; and it’s fully a hundred and fifty since yours was made last. Among the empirical falsifications characterised by the philosopher, Sir Karl Raimond Popper (1902–1994), there are remarkable empirical observations that have stood the test of thorough scientific scrutiny, each in their own way breaching his falsifiability criteria.
Allergies in the Workplace
OCCUPATIONAL ASTHMA IN A MUSHROOM FARM WORKER: A CASE OF MULTI-ALLERGEN SENSITISATION
Authors: Munyadziwa Muvhali, Christel T Nagoorsamy
Background: Occupational asthma is a significant but under-recognised respiratory disease among agricultural workers. Mushroom farming presents unique risks due to enclosed environments, high humidity, organic dust and other bio-aerosol exposures. Interstitial lung disease is well documented among mushroom workers, yet IgE-mediated asthma remains less frequently reported.
Case presentation: A 32-year-old female mushroom picker developed progressive respiratory symptoms associated with her work environment. Clinical evaluation confirmed asthma with significant post-bronchodilator reversibility (12% and 240 mL increase in FEV1 on spirometry) and > 20% variability in peak expiratory flow measurements, linked to workplace exposure. Immunological testing confirmed broad allergen sensitisation, with highly elevated IgE antibodies to house-dust mites (HMDs) Dermatophagoides pteronyssinus and D farinae, moderate sensitisation to grass pollens (Bermuda, ryegrass, timothy) and mild sensitisation to Rhizopus nigricans mould. The workplace assessment revealed the inadequate implementation of engineering control measures and the absence of respiratory protective equipment.
Discussion: The patient’s sensitisation profile highlights the complex interactions between atopy and occupational exposures. Although HDMs are typically domestic allergens, workplace organic dust may have exacerbated pre-existing sensitisation. Grass residues in mushroom farm compost and environmental moulds were likely triggers of occupational allergy. The case underscores the diagnostic challenge of distinguishing occupational from non-occupational allergens in farming environments, particularly when workers reside on-site.
Conclusion: This report documents a rare case of occupational asthma in a mushroom farm worker with multi-allergen sensitisation to environmental allergens, therefore emphasising the need to improve workplace control measures. These include conducting comprehensive workplace risk assessments, pursuing medical surveillance programmes, allergen monitoring and the use of appropriate respiratory protective equipment (RPE), all of which can be critical to preventing disease progression in similar agricultural settings.
Keywords: occupational asthma, mushroom farm worker, environmental allergens, atopy
Clinical review
PRURITIC DERMATOSES IN PREGNANCY: A CLINICAL REVIEW
Authors: Miguel J Teixeira, Jason Thoresen, Di Hawarden
Abstract: Pruritus is a frequent and often debilitating complaint during pregnancy, resulting from both physiological skin changes and pregnancy-specific dermatoses. Although many conditions are benign and self-limiting, others may carry important maternal and foetal risks. Pregnancy is characterised by complex immunological, hormonal and vascular changes that predispose women to different pruritic dermatoses. This review outlines the physiological cutaneous changes of pregnancy and provides a practical overview of the common pruritic dermatoses encountered during gestation, including atopic eruption during pregnancy, pemphigoid gestationis, polymorphic eruption of pregnancy, intrahepatic cholestasis of pregnancy, pustular psoriasis of pregnancy and chronic urticaria in pregnancy. Key aspects of the pathogenesis, clinical presentation, diagnosis, maternal–foetal implications and management are discussed, with a focus on their relevance to clinical practice in South Africa.
Keyword: pruritic dermatoses, pregnancy, foetal risks
Case report
A RARE PRESENTATION OF A DRUG-INDUCED ECZEMATOUS ERUPTION SECONDARY TO TELMISARTAN
Authors: Miguel J Teixeira, Jason Thoresen, Theresa Rossouw
Background: Cutaneous adverse drug reactions are the most common manifestation of drug hypersensitivity, with delayed (Type IV) T-cell-mediated responses representing a substantial proportion of them. Type IVb reactions are driven by Th2-polarised T-cells, which result in eosinophilic inflammation. Angiotensin receptor blockers (ARBs) are generally considered to be dermatologically safe; however, rare cutaneous reactions have previously been reported.
Case presentation: We present a 78-year-old male with progressive pruritic eczematous dermatitis affecting a gloveand-stocking distribution with truncal involvement. His histopathology was consistent with a drug eruption. Laboratory investigations revealed peripheral eosinophilia and elevated inflammatory markers. Lymphocyte proliferation testing (LPT) was positive to telmisartan (stimulation index 21), which confirmed drug-specific T-cell activation. The withdrawal of telmisartan, combined with short courses of oral corticosteroids and topical wet-wrap therapy, led to a marked clinical and laboratory improvement over a six-month period.
Discussion: This case highlights telmisartan as a potential trigger of a Type IVb delayed hypersensitivity reaction manifesting as drug-induced eczematous eruption. LPT is a useful in vitro adjunct that provides functional immunologic confirmation, supporting causality in the absence of high-risk drug-provocation testing. This case underscores the importance of considering chronic medications, even those with favourable safety profiles, as possible culprits in newonset eczematous eruptions in older adults.
Conclusion: Telmisartan-induced eczematous drug eruptions are rare, but can cause clinically significant morbidity. The integration of clinical, histopathological and functional immunological assays allows for the precise identification of the causative agent, avoids the need for a drug rechallenge and enables targeted management. This case expands the spectrum of ARB-associated cutaneous reactions and demonstrates the value of LPT in guiding clinical decisions.
Keywords: drug-induced eczematous eruption, telmisartan, cutaneous adverse drug reactions
Research article
PERSPECTIVES OF SOUTH AFRICAN CONSUMERS REGARDING FOOD ALLERGEN LABELLING ON ONLINE FOOD RETAIL PLATFORMS – A CROSS-SECTIONAL SURVEY
Authors: Rebecca PC Lee, Evette van Niekerk, Nelene Koen
Introduction: The growth of e-commerce in South Africa, including online food purchases, is burgeoning. This mode of purchasing has increased the need for accurate online food allergen labelling (FAL), rendering it essential to consumers with allergies or intolerances.
Objective: To evaluate South African consumers’ perspectives on online FAL. This study focused on accessibility, availability, the perceived importance of legislation and the correlations between allergen-seekers and non-seekers and their preferred presentation of food allergen information (FAI) on user interfaces.
Methods: A descriptive cross-sectional study with an analytical component was conducted with a group of consumers (n = 87). Snowball sampling and a validated online survey distributed through social media were used.
Results: Consumers who sought FAI online (45%) faced problems of accessibility (67%). Many struggled with identifying (69%), locating (62%) and interpreting (49%) FAI online. Furthermore, some consumers were dissatisfied (62%) with the available online FAI, having reported inconsistency (69%), and felt uninformed (62%). A gap exists between the perceived variety of FAI online (46%) and its sufficiency (23%). In addition, correlations between FAI-seekers and non-seekers were found for product images (p = 0.006) and food allergen icons (p = 0.070). Overall, most of the consumers (87%) valued access to FAI when e-shopping and supported (99%) online FAL legislation.
Conclusion: Online food allergen labelling should be clear, accurate and strictly regulated.
Keywords: online food allergen labelling, food allergy, legislation, consumer perspectives, e-grocery
ABC of Allergy
Type 2 inflammation: where does IgE fit in?
Authors: Shaunagh Emanuel, Di Hawarden
Introduction: Type 2 inflammation involves several interconnected pathways, including IgE-mediated allergy. It involves coordinated innate and adaptive immune responses, including T-helper 2 (Th2) cells, Type 2 innate lymphoid cells (ILC2s), eosinophils, mast cells, basophils and Type 2 cytokines. IgE-mediated responses are an important component of this network, but Type 2 inflammation can also occur independently of allergen-specific IgE.
DR SPUR’S MYSTERY CASE
When the family tree holds the clue
Authors: Petri Swanepoel, Sylvia van den Berg, Louise Murray
Abstract: Given the recurrent history of severe illness and death in male infants across the maternal family, an inherited immunodeficiency, particularly X-linked severe combined immunodeficiency (SCID), is a significant consideration.1,2 Prompt investigation and management are warranted, while at the same time recognising that other genetic and non-genetic causes of severe infantile disease should also be considered.
Nutrition Tuition
BACK TO BASICS: COW’S MILK PROTEIN ALLERGY OR MILK ALLERGY?
Author: Jandri Barnard
Introduction: In all our practices, we find patients of all ages complaining about a ‘milk’ or ‘dairy’ allergy or even ‘lactose intolerance’. Most of these are self-diagnosed and so we need to unravel the science behind the fiction in order to make a correct diagnosis and offer a sufficient way forward for these patients (or parents of patients) to adapt their lifestyles accordingly. To begin, I would like to compare cow’s milk protein allergy (CMPA), milk or dairy allergy and lactose intolerance.